Margot De Spiegeleer

Margot De Spiegeleer

Auto-generated profile, based on publicly available information

Margot De Spiegeleer

Ghent University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Analytica Chimica Acta
Verified
Journal Article
Closed access
MSMargot De Spiegeleer
Margot De Spiegeleer
MGMarilyn De Graeve
Marilyn De Graeve
SHSteve Huysman
Steve Huysman
AVArno Vanderbeke
Arno Vanderbeke
LMLieven Van Meulebroek
Lieven Van Meulebroek
LVLynn Vanhaecke
Lynn Vanhaecke

2 August 2021 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
VPVera Plekhova
Vera Plekhova
LMLieven Van Meulebroek
Lieven Van Meulebroek
MGMarilyn De Graeve
Marilyn De Graeve
APAlvaro Perdones-Montero
Alvaro Perdones-Montero
MSMargot De Spiegeleer
Margot De Spiegeleer
LVLynn Vanhaecke
Lynn Vanhaecke

1 September 2020 in Talanta
Verified
Journal Article
Closed access
LMLieven Van Meulebroek
Lieven Van Meulebroek
SCSimon Cameron
Simon Cameron
VPVera Plekhova
Vera Plekhova
MSMargot De Spiegeleer
Margot De Spiegeleer
KWKathleen Wijnant
Kathleen Wijnant
LVLynn Vanhaecke
Lynn Vanhaecke

17 September 2023 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Open access
VPVera Plekhova
Vera Plekhova
KWKimberly De Windt
Kimberly De Windt
MSMargot De Spiegeleer
Margot De Spiegeleer
MGMarilyn De Graeve
Marilyn De Graeve
LVLynn Vanhaecke
Lynn Vanhaecke

9 June 2023 in Science Advances
Verified
Journal Article
Open access
MSMargot De Spiegeleer
Margot De Spiegeleer
VPVera Plekhova
Vera Plekhova
JGJozefien Geltmeyer
Jozefien Geltmeyer
ESElla Schoolaert
Ella Schoolaert
BPBeata Pomian
Beata Pomian
LVLynn Vanhaecke
Lynn Vanhaecke
In recent years, ambient ionization mass spectrometry (AIMS) including laser ablation rapid evaporation IMS, has enabled direct biofluid metabolome analysis. AIMS procedures are, however, still hampered by both analytical, i.e., matrix effects, and practical, i.e., sample transport stability, drawbacks that impede metabolome coverage. In this study, we aimed at developing biofluid-specific metabolome sampling membranes (MetaSAMPs) that offer a directly applicable and stabilizing substrate for AIMS. Customized rectal, salivary, and urinary MetaSAMPs consisting of electrospun (nano)fibrous membranes of blended hydrophilic (polyvinylpyrrolidone and polyacrylonitrile) and lipophilic (polystyrene) polymers supported metabolite absorption, adsorption, and desorption. Moreover, MetaSAMP demonstrated superior metabolome coverage and transport stability compared to crude biofluid analysis and was successfully validated in two pediatric cohorts (MetaBEAse, n = 234 and OPERA, n = 101). By integrating anthropometric and (patho)physiological with MetaSAMP-AIMS metabolome data, we obtained substantial weight-driven predictions and clinical correlations. In conclusion, MetaSAMP holds great clinical application potential for on-the-spot metabolic health stratification.

24 April 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
MSMargot De Spiegeleer
Margot De Spiegeleer
VPVera Plekhova
Vera Plekhova
JGJozefien Geltmeyer
Jozefien Geltmeyer
ESElla Schoolaert
Ella Schoolaert
BPBeata Pomian
Beata Pomian
LVLynn Vanhaecke
Lynn Vanhaecke
While rapid analysis of the human biofluid metabolome is now possible using ambient ionization mass spectrometry (AIMS), these procedures are hampered by in-source matrix effects and reduced sample stability impeding metabolome coverage while remaining relatively labor-intensive. In this study, we aimed at developing biofluid-specific metabolome sampling membranes (MetaSAMP®s, WO2021/191467) that offer a directly applicable and stabilizing substrate for AIMS. Customized rectal, salivary and urinary MetaSAMP®s consisting of multilayered electrospun nanofibrous membranes of blended hydrophilic (polyvinylpyrrolidone and polyacrylonitrile) and lipophilic (polystyrene) polymers supported adequate metabolite ab- , ad-, and desorption. Moreover, MetaSAMP® demonstrated superior metabolome coverage and transport stability compared to crude biofluid analysis and was successfully validated in two pediatric cohorts (MetaBEAse, n=234, feces and urine; OPERA, n=138, saliva). By integrating anthropometric and (patho)physiological with MetaSAMP®-AIMS metabolome data, we obtained significant weight-driven predictions and clinical correlations. In conclusion, MetaSAMP® holds great clinical application potential for on-the-spot metabolic health stratification.